ABT - Abbott Laboratories Stock Price, Fair Value and News

$115.91-1.22 (-1.04%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ABT Price Action

Last 7 days

0.2%

Last 30 days

-0.9%

Last 90 days

3.4%

Trailing 12 Months

13.7%

ABT RSI Chart

ABT Valuation

Market Cap

201.6B

Price/Earnings (Trailing)

34.96

Price/Sales (Trailing)

4.89

EV/EBITDA

25.52

Price/Free Cashflow

31.09

ABT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ABT Fundamentals

ABT Revenue

Revenue (TTM)

41.2B

Rev. Growth (Yr)

4.85%

Rev. Growth (Qtr)

2.49%

ABT Earnings

Earnings (TTM)

5.8B

Earnings Growth (Yr)

14.62%

Earnings Growth (Qtr)

26.42%

ABT Profitability

EBT Margin

16.44%

Return on Equity

14.49%

Return on Assets

7.76%

Free Cashflow Yield

3.22%

ABT Investor Care

Dividend Yield

1.9%

Dividend/Share (TTM)

2.2

Shares Dilution (1Y)

0.04%

Diluted EPS (TTM)

3.29

ABT Alerts

1 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	40.3B	40.7B	41.2B	0
2023	41.5B	40.2B	40.0B	40.1B
2022	44.5B	45.5B	45.0B	43.7B
2021	37.3B	40.2B	42.3B	43.1B
2020	32.1B	31.4B	32.2B	34.6B
2019	30.7B	30.9B	31.4B	31.9B
2018	28.4B	29.6B	30.4B	30.6B
2017	22.3B	23.6B	25.1B	27.4B
2016	20.4B	20.6B	20.7B	20.9B
2015	20.4B	20.5B	20.6B	20.4B
2014	19.6B	19.7B	20.0B	20.2B
2013	21.1B	20.7B	20.2B	19.7B
2012	35.1B	30.8B	26.2B	21.5B
2011	36.5B	37.3B	38.4B	38.9B
2010	31.7B	33.1B	34.0B	35.2B
2009	0	0	0	30.8B

Get all data in R, Python etc through our Historical Stock Data APIs

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, MÃƒÆ’Ã‚Â©niÃƒÆ’Ã‚Â¨re's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

CEO	Mr. Robert B. Ford
WEBSITE	abbott.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	65535

Abbott Laboratories Frequently Asked Questions

What is the ticker symbol for Abbott Laboratories? What does ABT stand for in stocks?

ABT is the stock ticker symbol of Abbott Laboratories. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Abbott Laboratories (ABT)?

As of Wed Nov 20 2024, market cap of Abbott Laboratories is 201.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ABT stock?

You can check ABT's fair value in chart for subscribers.

Is Abbott Laboratories a good stock to buy?

The fair value guage provides a quick view whether ABT is over valued or under valued. Whether Abbott Laboratories is cheap or expensive depends on the assumptions which impact Abbott Laboratories's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ABT.

What is Abbott Laboratories's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, ABT's PE ratio (Price to Earnings) is 34.96 and Price to Sales (PS) ratio is 4.89. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ABT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Abbott Laboratories's stock?

In the past 10 years, Abbott Laboratories has provided 0.102 (multiply by 100 for percentage) rate of return.